Compare Celestica Inc (CLS) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Celestica Inc vs Smith & Nephew plc — how do they compare? Celestica Inc trades at $315.93 (market cap $39.16B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: Celestica Inc is far larger — about 3.1× Smith & Nephew plc's market cap, and Smith & Nephew plc pays a 2.65% dividend while Celestica Inc pays none. Which is the better fit depends on your goals.
| CLS | SNN | |
|---|---|---|
Market Cap | $39.16B | $12.54B |
Sector | Technology | Health |
52-Week High | $472.40 | $38.70 |
52-Week Low | $181.34 | $28.73 |
Enterprise Value | $39.44B | $15.57B |
Dividend Yield | — | 2.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Celestica Inc
Celestica provides supply chain and manufacturing solutions for global technology companies. It specializes in high-complexity assembly and platform solutions for AI data centers, aerospace, and medical markets.
Read more on CLS →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
